Home›Companies›Biotech & Pharma›Insigna

Insigna, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 8, 2025·Suggest an edit

About Insigna

Insigna is a private company based in Champaign, Illinois. It has reported $8,535,359 raised in four offerings on Form D since June 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 22, 2025Feb 18, 2025amended Jul 8, 2025$4,000,032target not set2$2.0MEquityRule 506(b)Form D/A ↗1 earlier filing
Nov 23, 2022Dec 27, 2022amended Mar 10, 2023$1,166,927target not set7$166KEquityRule 506(b)Form D/A ↗1 earlier filing
Aug 8, 2022Aug 10, 2022$2,000,000target not set1$2.0MEquityRule 506(b)Form D ↗
May 23, 2019Jun 21, 2019$1,368,400of $2.0M target18$76,022EquityRule 506(b)Form D ↗
Total, four offerings$8,535,359

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Insigna's Form D filed Jul 8, 2025.

BW
Byron Wittenberg
Executive officer and director
CK
CheMyong Ko
President and director

Sources

  1. SECInsigna, Inc. Form D, filed Feb 18, 2025
  2. SECInsigna, Inc. Form D, filed Dec 27, 2022
  3. SECInsigna, Inc. filing history